MedTrace Logo

ProtocoL for GFR Measurement Using Iohexol (SCOPE-PLUS) - A Substudy of the SCOPE Study

NCT04449172 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2024-03-05

No results posted yet for this study

Summary

SCOPE-PLUS is an optional substudy of the observational SCOPE Study (Screening for Chronic Kidney Disease among Older People across Europe, NCT02691546). The objective of the SCOPE-PLUS study is to derive new equations based on innovative and novel biomarkers of CKD function and compare its accuracy to measure GFR in the population older than 75 years.

Conditions

  • Chronic Kidney Diseases

Sponsors & Collaborators

  • Erasmus Medical Center

    collaborator OTHER

  • Institut Catala de Salut

    collaborator OTHER_GOV

  • Medical University of Graz

    collaborator OTHER

  • Istituto Nazionale di Ricovero e Cura per Anziani

    lead OTHER

Eligibility

Min Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-08-08
Primary Completion
2021-08-30
Completion
2021-08-30

Countries

  • Austria
  • Italy
  • Netherlands
  • Spain

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04449172 on ClinicalTrials.gov